Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testing
about
eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variantsInvestigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of GujaratCohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS).
P2860
Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testing
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@ast
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@en
type
label
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@ast
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@en
prefLabel
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@ast
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@en
P2860
P356
P1476
Loss-of-function CYP2C9 varian ...... abetes pharmacogenetic testing
@en
P2093
Deborah J Wexler
P2860
P304
P356
10.1586/ERC.10.5
P577
2010-03-01T00:00:00Z